Clorox Q1 FY2026: Net sales down 19% to $1.43B, adj. EPS $0.85 (-54% YoY) on ERP disruption

CLOROX CO /DE/

2026-Q1 EPS reported $0.65 vs consensus $1.57 ▼ miss (-58.5%)

Diluted EPS $0.65 vs $0.80 prior year; adjusted EPS $0.85 vs $1.86 (-54%), largely due to ERP transition.
Gross margin fell 410 bps to 41.7% on lower volume and higher manufacturing/logistics costs.
Organic sales declined 17%, with volume down 15%; Health & Wellness segment sales -19%.
Operating cash flow $93M vs $221M (-58%); free cash flow $57M vs $182M.
Company cites expected ERP transition impact; no specific numerical guidance revision provided.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.